Evaluation of clinical case definitions of influenza: Detailed investigation of patients during the 1995-1996 epidemic in France

Clinical Infectious Diseases

Volumn 28, Issue 2, 1999, Pages 283-290

  Carrat, Fabrice ^a,b   Tachet, Anne ^a,b   Rouzioux, Christine ^a,b   Housset, Bruno ^a,b   Valleron, Alain Jacques ^a,b  

^a Inst Natl de la Sante et de la R   (France)

^b CENTRE HOSPITALIER INTERCOMMUNAL DE CRÉTEIL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; BODY TEMPERATURE; CHILD; COUGHING; EPIDEMIC; FATIGUE; FRANCE; HUMAN; INFECTION RATE; INFLUENZA; LACRIMATION; MAJOR CLINICAL STUDY; MYALGIA; PRIORITY JOURNAL; RHINORRHEA; STRAIN DIFFERENCE; SYMPTOMATOLOGY;

EID: 0032970990     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/515117     Document Type: Article

References (44)

1. 1. Sullivan KM, Monto AS, Longini IM. Estimates of the US health impact of influenza. Am J Public Health 1993;83:1712-6.
2. 2. Glezen WP. Serious morbidity and mortality associated with influenza epidemics. Epidemiol Rev 1982;4:25-44.
3. 3. Costagliola D, Flahault A, Galinec D, Garnerin P, Menares J, Valleron A-J. A routine tool for detection and assessment of epidemics of influenza-like syndromes in France. Am J Public Health 1991;81:97-9.
4. 4. Lui K-J, Kendal AP. Impact of influenza epidemics on mortality in the United States from October 1972 to May 1985. Am J Public Health 1987;77:712-6.
5. 5. Tillet HE, Smith JWG, Gooch CD. Excess deaths attributable to influenza in England and Wales: age at death and certified cause. Int J Epidemiol 1983;12:344-52.
6. 6. Sprenger MJW, Van Naelten MAMG, Mulder PGH, Masurel N. Influenza mortality and excess deaths in the elderly, 1967-1982. Epidemiol Infect 1989;103:633-41.
7. 7. Nicholson KG. Impact of influenza and respiratory syncytial virus on mortality in England and Wales from January 1975 to December 1990. Epidemiol Infect 1996;116:51-63.
8. 8. Barker WH, Mullooly JP. Pneumonia and influenza deaths during epidemics. Implications for prevention. Arch Intern Med 1982;142:85-9.
9. 9. Carrat F, Valleron A-J. Influenza mortality among the elderly. How many deaths may have been avoided through vaccination? J Epidemiol Community Health 1995;49:419-25.
10. 10. Schoenbaum SC. Economic impact of influenza. The individual's perspective. Am J Med 1987;82(suppl 6A):26-30.
11. 11. McBean AM, Babish JD, Warren JL. The impact and cost of influenza in the elderly. Arch Intern Med 1993;153:2105-11.
12. 12. Cox NJ, Brammer L, Regnery HL. Influenza: global surveillance for epidemic and pandemic variants. Eur J Epidemiol 1994;10:467-70.
13. 13. Fleming DM, Chakraverty P, Sadler C, Litton P. Combined clinical and virological surveillance of influenza in winters of 1992 and 1993-4. BMJ 1995;311:290-1.
14. 14. Monto AS, Ohmit SE, Margulies JR, Talsma A. Medical practice-based influenza surveillance: viral prevalence and assessment of morbidity. Am J Epidemiol 1995;141:502-6.
15. 15. Barker WH, Menegus MA, Hall CB, et al. Communitywide laboratory-based influenza surveillance focused on older persons, 1989-1992. Am J Prev Med 1995;11:149-55.
16. 16. Monto AS. Influenza: quantifying morbidity and mortality. Am J Med 1987;82(suppl 6A):20-5.
17. 17. Nicholson KG, Baker DJ, Farquhar A, Hurd D, Kent J, Smith SH. Acute respiratory tract viral illness and influenza immunization in homes for the elderly. Epidemiol Infect 1990;105:609-18.
18. 18. Monto AS, Sullivan KM. Acute respiratory illness in the community. Frequency of illness and the agents involved. Epidemiol Infect 1993;110:145-60.
19. 19. Monto AS. Studies of the community and family: acute respiratory illness and infection. Epidemiol Rev 1994;16:351-73.
20. 20. Taylor JL, Dwyer DM, Coffman T, Groves C, Patel J, Israel E. Nursing home outbreak of influenza A(H3N2): evaluation of vaccine efficacy and influenza case definitions. Infect Control Hosp Epidemiol 1992;13: 93-7.
21. 21. Carrat F, Tachet A, Housset B, Valleron A-J, Rouzioux C. Influenza and influenza-like illness in general practice. Drawing lessons for surveillance from a pilot study in Paris, France. Br J Gen Pract 1997;47: 217-20.
22. 22. Carrat F, Flahault A, Boussard E, Farran N, Dangoumeau L, Valleron A-J. Surveillance of influenza-like illness in France. The example of the 1995/1996 epidemic. J Epidemiol Community Health 1998;52(suppl 1):32S-8S.
23. 23. Wright KE, Wilson GAR, Novosad D, Dimock C, Tan D, Weber JM. Typing and subtyping of influenza viruses in clinical samples by PCR. J Clin Microbiol 1995;33:1180-4.
24. 24. Lemeshow S, Hosmer DW. A review of goodness of fit statistics for use in the development of logistic regression models. Am J Epidemiol 1982;115:92-106.
25. 25. Govaert TME, Thijs CTMCN, Masurel N, Sprenger MJW, Dinant GJ, Knottnerus JA. The efficacy of influenza vaccination in elderly individuals. A randomized double-blind placebo-controlled trial. JAMA 1994;272:1661-5.
26. 26. Buffington J, Chapman LE, Schmeltz LM, Kendal AP. Do family physicians make good sentinels for influenza. Arch Fam Med 19932:859-65.
27. 27. Cate TR. Clinical manifestations and consequences of influenza. Am J Med 1987;82(suppl 6A):15-9.
28. 28. Jordan WS, Denny FW, Badger GF, et al. A study of illness in a group of Cleveland families. XVII. The occurrence of Asian influenza. Am J Hyg 1958;68:190-212.
29. 29. Frank AL, Taber LH, Wells JM. Comparison of infection rates and severity of illness for influenza A subtypes H1N1 and H3N2. J Infect Dis 1985;151:73-801.
30. 30. Everett MT. The flu-like illness. Practitioner 1977;219:699-711.
31. 31. Nicholson KG, Kent J, Hammersley V, Cancio E. Acute viral infections of upper respiratory tract in the elderly people living in the community: comparative, prospective population-based study of disease burden. BMJ 1997;315:1060-4.
32. 32. Hope-Simpson RE, Higgins PG. A respiratory virus study in Great Britain: review and evaluation. Prog Med Virol 1969;11:354-407.
33. 33. Monto AS, Ohmit SE. The evolving epidemiology of influenza infection and disease. In: Brown LE, Hampson AW, Webster RG, eds. Options for the control of influenza III. Amsterdam: Excerpta Medica, 1996: 45-9.
34. 34. Lina B, Valette M, Foray S, et al. Surveillance of community-acquired viral infections due to respiratory viruses in Rhone-Alpes (France) during winter 1994 to 1995. J Clin Microbiol 1996;34:3007-11.
35. 35. Grandien M, Petterson C-A, Gardner PS, Linde A, Stanton A. Rapid viral diagnosis of acute respiratory infections: comparison of enzyme-linked immunosorbent assay and the immunofluorescence technique for detection of viral antigens in nasopharyngeal secretions. J Clin Microbiol 1985;22:757-60.
36. 36. Chomel JJ, Thouvenot D, Onno M, Kaiser C, Gourreau JM, Aymard M. Rapid diagnosis of influenza infection of NP antigen using an immunocapture ELISA test. J Virol Methods 1989;25:81-92.
37. 37. Döller G, Schuy W, Tjhen KY, Stekeler B, Gerth H-J. Direct detection of influenza virus antigen in nasopharyngeal specimens by direct enzyme immunoassay in comparison with quantitating virus shedding. J Clin Microbiol 1992;30:866-9.
38. 38. Chomel J-J, Remilleux MF, Marchand P, Aymard M. Rapid diagnosis of influenza A. Comparison with ELISA immunocapture and culture. J Virol Methods 1992;37:337-44.
39. 39. Leonardi GP, Leib H, Birkhead GS, Smith C, Costello P, Conron W. Comparison of rapid detection methods for influenza A virus and their value in health-care management of institutionalized geriatric patients. J Clin Microbiol 1994;32:70-4.
40. 40. Spada B, Biehler K, Chegas P, Kaye J, Riepenhoff-Talty M. Comparison of rapid immunofluorescence assay to cell culture isolation for the detection of influenza A and B viruses in nasopharyngeal secretions from infants and children. J Virol Methods 1991;33:305-10.
41. 41. Monto AS, Koopman JS, Longini IM. Tecumseh study of illness. XIII. Influenza infection and disease, 1976-1981. Am J Epidemiol 1985;121:811-22.
42. 42. Glezen WP, Keitel WA, Taber LH, Piedra PA, Clover RD, Couch RB. Age distribution of patients with medically-attended illnesses caused by sequential variants of influenza A/H1N1: comparison to age-specific infection rates, 1978-1989. Am J Epidemiol 1991;133:595-600.
43. 43. Carrat F, Tachet A, Rouzioux C, Housset B, Valleron A-J. Field investigation of influenza vaccine effectiveness on morbidity. Vaccine 1998;16: 893-8.
44. 44. Hayden FG, Osterhaus ADME, Treanor JJ, et al. Efficacy and safety of the neuraminidase inhibitor zanamivir in the treatment of Influenzavirus infections. N Engl J Med 1997;337:878-80.